Skip Ribbon Commands
Skip to main content


32.5G Pen Needle


The Nanopass 32.5G pen needle is intended for use with a pen injector device for the subcutaneous injection of drugs including insulin and human growth hormone.

The ​Nanopass 32.5-range offers three different lengths - allowing to choose the suitable pen needle for each patient type.

Terumo has put its knowledge about reducing injection pain into the design of Nanopass 32.5G. Also users of long needles will benefit from it.

Nanopass 32.5G offers patients a more convenient insulin injection by applying dedicated Terumo technologies.


  • ​Asymetric bevel1

    ​​The unique asymmetric bevelof Nanopass cuts the skin instead of puncturing it. This decreases the resistance while penetrating the skin – designed to reduce pain.2

  • Special thin pen needle size

    ​The special thin pen needle size of only 32.5G (0.22 mm) causes less skin trauma than larger needle sizes.3

  • Terumo-thin wall technology

    ​The large inner diameter of Nanopass 32.5G optimizes the insulin flow for an easy insulin injection.

  • ​Colour coding

    ​Colour Coding for easy identification of the preferred pen needle length.

Item specifications


tip diameter​

(Ø 0.22 mm)

4 mmTN*32504M100 pieces
(Ø 0.22 mm)
6 mm TN*32506M100 pieces
(Ø 0.22 mm)
8 mmTN*32508M100 pieces

 Regulatory symbols_EN.png


Nanopass® pen needles are compatible with the following pen devices:

Novo Nordisk

FlexPen®, FlexTouch®, NovoPen®4, NovoPen®5, NovoPen Echo®, InnoLet®, Victoza® Pen​


​AllStar®, ClikStar®, JuniorStar®, SoloStar®, TactiPen®, Lyxumia®

Eli Lilly

​HumaPen® Luxura, HumaPen®Luxura HD, HumaPen®Memoir, HumaPen®Savvio, KwikPenTM, HumatroPen®
Berlin-Chemie​BerliPen®Junior, BerliPen®Precision, BerliPen®Areo 2
​Owen Mumford​Autopen®Classic 1, Autopen®Classic 2, Autopen®24-1, Autopen®24-2
​FerringFERRING Pen


​Diapen®3.1, Diapen®3.2


​pendiq® Pen

The brands listed are the property of the named companies.

Please note that some products may not be available in all regions. Check with your local TERUMO office or your local TERUMO Pharmaceuticals Solutions contact for details.


Relevant product information
Nanopass 32.5G brochure (Diabetes Care)


1  Patented technology.
2  Intra company data show less puncture resistance for the asymmetric edge compared to a standard 3-bevel. Lower puncture resistance is related to lower pain (T. Asakura, 2013, Jpn J Med Pharm Sci 69(1):147-155).
The size of the perforation scar correlates with the outer diameter of the needle (T. Asakura, H. Seino, 2004, Jpn J Pharm. Health Care Sci., 30(6):368-376).

Do you need more info?

Our sales representatives are here for you

Contact us

Didn't find your product?

Consult our products in our Product Index

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public